Insulin affordability advocates reckon with road ahead for $35-a-month price cap

Advocates for affordable diabetes medications are regrouping and reconsidering strategies for legislation to lower the cost of insulin and other diabetes medications after the Senate passed a limited cost-saving measure that will leave out the majority of insulin users.

Related Keywords

Louisiana ,United States ,Maine ,Missouri ,Alaska ,Mississippi ,Americans ,America ,Susan Collins ,Bill Cassidy ,Josh Hawley ,George Huntley ,Dan Sullivan ,John Kennedy ,Cindy Hyde Smith ,David Mitchell ,Lisa Murkowski ,Senate Majority Leader Chuck Schumer ,Health Care Cost Institute ,Senate Republicans ,Senate Democrats ,Diabetes Patient Advocacy Coalition ,Diabetes Leadership Council ,Inflation Reduction Act ,Diabetes Leadership ,Health Care Cost ,Patients For Affordable Drugs ,Jeanne Shaheen ,Raphael Warnock ,Diabetes Patient Advocacy ,Majority Leader Chuck Schumer ,Inflation ,Insulin ,